215 related articles for article (PubMed ID: 17855048)
1. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
[TBL] [Abstract][Full Text] [Related]
2. Rubinstein-Taybi Syndrome: spectrum of CREBBP mutations in Italian patients.
Bentivegna A; Milani D; Gervasini C; Castronovo P; Mottadelli F; Manzini S; Colapietro P; Giordano L; Atzeri F; Divizia MT; Uzielli ML; Neri G; Bedeschi MF; Faravelli F; Selicorni A; Larizza L
BMC Med Genet; 2006 Oct; 7():77. PubMed ID: 17052327
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.
Rusconi D; Negri G; Colapietro P; Picinelli C; Milani D; Spena S; Magnani C; Silengo MC; Sorasio L; Curtisova V; Cavaliere ML; Prontera P; Stangoni G; Ferrero GB; Biamino E; Fischetto R; Piccione M; Gasparini P; Salviati L; Selicorni A; Finelli P; Larizza L; Gervasini C
Hum Genet; 2015 Jun; 134(6):613-26. PubMed ID: 25805166
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.
Bartsch O; Rasi S; Delicado A; Dyack S; Neumann LM; Seemanová E; Volleth M; Haaf T; Kalscheuer VM
Hum Genet; 2006 Sep; 120(2):179-86. PubMed ID: 16783566
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.
Fergelot P; Van Belzen M; Van Gils J; Afenjar A; Armour CM; Arveiler B; Beets L; Burglen L; Busa T; Collet M; Deforges J; de Vries BB; Dominguez Garrido E; Dorison N; Dupont J; Francannet C; Garciá-Minaúr S; Gabau Vila E; Gebre-Medhin S; Gener Querol B; Geneviève D; Gérard M; Gervasini CG; Goldenberg A; Josifova D; Lachlan K; Maas S; Maranda B; Moilanen JS; Nordgren A; Parent P; Rankin J; Reardon W; Rio M; Roume J; Shaw A; Smigiel R; Sojo A; Solomon B; Stembalska A; Stumpel C; Suarez F; Terhal P; Thomas S; Touraine R; Verloes A; Vincent-Delorme C; Wincent J; Peters DJ; Bartsch O; Larizza L; Lacombe D; Hennekam RC
Am J Med Genet A; 2016 Dec; 170(12):3069-3082. PubMed ID: 27648933
[TBL] [Abstract][Full Text] [Related]
6. High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.
Gervasini C; Mottadelli F; Ciccone R; Castronovo P; Milani D; Scarano G; Bedeschi MF; Belli S; Pilotta A; Selicorni A; Zuffardi O; Larizza L
Eur J Hum Genet; 2010 Jul; 18(7):768-75. PubMed ID: 20125191
[TBL] [Abstract][Full Text] [Related]
7. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS.
Bartsch O; Schmidt S; Richter M; Morlot S; Seemanová E; Wiebe G; Rasi S
Hum Genet; 2005 Sep; 117(5):485-93. PubMed ID: 16021471
[TBL] [Abstract][Full Text] [Related]
8. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.
Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C
Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927
[TBL] [Abstract][Full Text] [Related]
9. Clinical and mutational spectrum in Korean patients with Rubinstein-Taybi syndrome: the spectrum of brain MRI abnormalities.
Lee JS; Byun CK; Kim H; Lim BC; Hwang H; Choi JE; Hwang YS; Seong MW; Park SS; Kim KJ; Chae JH
Brain Dev; 2015 Apr; 37(4):402-8. PubMed ID: 25108505
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of CREBBP gene dosage anomalies in Rubinstein-Taybi syndrome patients.
Stef M; Simon D; Mardirossian B; Delrue MA; Burgelin I; Hubert C; Marche M; Bonnet F; Gorry P; Longy M; Lacombe D; Coupry I; Arveiler B
Eur J Hum Genet; 2007 Aug; 15(8):843-7. PubMed ID: 17473832
[TBL] [Abstract][Full Text] [Related]
11. A Novel CREBBP in-Frame Deletion Variant in a Chinese Girl with Atypical Rubinstein-Taybi Syndrome Phenotypes.
Wang Q; Xu W; Liu Y; Yuan H
J Mol Neurosci; 2021 Mar; 71(3):607-612. PubMed ID: 32839936
[TBL] [Abstract][Full Text] [Related]
12. Clinical exome sequencing identifies novel CREBBP variants in 18 Chinese Rubinstein-Taybi Syndrome kids with high frequency of polydactyly.
Yu S; Wu B; Qian Y; Zhang P; Lu Y; Dong X; Wang Q; Zhao X; Liu R; Zhou W; Wang H
Mol Genet Genomic Med; 2019 Dec; 7(12):e1009. PubMed ID: 31637876
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene.
Negri G; Milani D; Colapietro P; Forzano F; Della Monica M; Rusconi D; Consonni L; Caffi LG; Finelli P; Scarano G; Magnani C; Selicorni A; Spena S; Larizza L; Gervasini C
Clin Genet; 2015 Feb; 87(2):148-54. PubMed ID: 24476420
[TBL] [Abstract][Full Text] [Related]
14. Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH.
Tsai AC; Dossett CJ; Walton CS; Cramer AE; Eng PA; Nowakowska BA; Pursley AN; Stankiewicz P; Wiszniewska J; Cheung SW
Eur J Hum Genet; 2011 Jan; 19(1):43-9. PubMed ID: 20717166
[TBL] [Abstract][Full Text] [Related]
15. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.
López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E
BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490
[TBL] [Abstract][Full Text] [Related]
16. New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients.
Pérez-Grijalba V; García-Oguiza A; López M; Armstrong J; García-Miñaur S; Mesa-Latorre JM; O'Callaghan M; Pineda Marfa M; Ramos-Arroyo MA; Santos-Simarro F; Seidel V; Domínguez-Garrido E
Mol Genet Genomic Med; 2019 Nov; 7(11):e972. PubMed ID: 31566936
[TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical heterogeneity in Korean patients with Rubinstein-Taybi syndrome.
Choi N; Kim HY; Lim BC; Chae JH; Kim SY; Ko JM
Mol Genet Genomic Med; 2021 Oct; 9(10):e1791. PubMed ID: 34427995
[TBL] [Abstract][Full Text] [Related]
18. Rubinstein-Taybi syndrome: clinical and molecular overview.
Roelfsema JH; Peters DJ
Expert Rev Mol Med; 2007 Aug; 9(23):1-16. PubMed ID: 17942008
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line IGIBi18-A from an Indian patient with Rubinstein Taybi Syndrome.
Verma S; Dalabehera S; Maurya R; Singh D; Prasher B; Pandey R; Bapat S; Ramalingam S; Sachidanandan C
Stem Cell Res; 2024 Aug; 78():103456. PubMed ID: 38820863
[TBL] [Abstract][Full Text] [Related]
20. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
